Two distinct knockout approaches highlight a critical role for p53 in rat development

Scientific Reports

Volumn 2, Issue , 2012, Pages

  Kawamata, Masaki ^a   Ochiya, Takahiro ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ANIMAL; ANIMAL MODEL; APOPTOSIS; ARTICLE; BLASTOCYST; CELL DIFFERENTIATION; CELL LINE; CHROMOSOMAL INSTABILITY; CYTOLOGY; EMBRYO DEVELOPMENT; EMBRYONIC STEM CELL; FEMALE; GENE EXPRESSION PROFILING; GENE INACTIVATION; GENETICS; HOMOZYGOTE; MALE; METABOLISM; RAT;

ANIMALS; APOPTOSIS; BLASTOCYST; CELL DIFFERENTIATION; CELL LINE; CHROMOSOMAL INSTABILITY; EMBRYONIC DEVELOPMENT; EMBRYONIC STEM CELLS; FEMALE; GENE EXPRESSION PROFILING; GENE KNOCKOUT TECHNIQUES; HOMOZYGOTE; MALE; MODELS, ANIMAL; RATS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84871769801     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep00945     Document Type: Article

References (38)

1. Cozzi, J. et al. Pronuclear DNA injection for the production of transgenic rats. Methods Mol. Biol. 561, 73-88 (2009).
2. Dann, C. T., Alvarado, A. L., Hammer, R. E. & Garbers, D. L. Heritable and stable gene knockdown in rats. Proc. Natl. Acad. Sci. U S A. 103, 11246-11251 (2006). (Pubitemid 44156504)
3. Zan, Y. et al. Production of knockout rats using ENU mutagenesis and a yeastbased screening assay. Nat. Biotechnol. 21, 645-651 (2003). (Pubitemid 36638091)
4. van Boxtel, R., Gould, M. N., Cuppen, E. & Smits, B. M. ENU mutagenesis to generate genetically modified rat models. Methods Mol. Biol. 597, 151-167 (2010).
5. Kitada, K. et al. Transposon-tagged mutagenesis in the rat. Nat. Methods 4, 131-133 (2007). (Pubitemid 46454680)
6. Kitada, K., Keng, V. W., Takeda, J. & Horie, K. Generating mutant rats using the Sleeping Beauty transposon system. Methods 49, 236-242 (2009).
7. Izsvák, Z. et al. Generating knockout rats by transposon mutagenesis in spermatogonial stem cells. Nat. Methods 7, 443-445 (2010).
8. Geurts, A. M. et al. Knockout rats via embryo microinjection of zinc-finger nucleases. Science 325, 433 (2009).
9. Mashimo, T. et al. Generation of knockout rats with X-linked severe combined immunodeficiency (X-SCID) using zinc-finger nucleases. PLoS One 5, e8870 (2010).
10. Buehr, M. et al. Capture of authentic embryonic stem cells from rat blastocysts. Cell 135, 1287-1298 (2008).
11. Li, P. et al. Germline competent embryonic stem cells derived from rat blastocysts. Cell 135, 1299-1310 (2008).
12. Kawamata, M. & Ochiya, T. Generation of genetically modified rats from embryonic stem cells. Proc. Natl. Acad. Sci. USA 107, 14223-14228 (2010).
13. Hamanaka, S. et al. Generation of germline-competent rat induced pluripotent stem cells. PLoS One 6, e22008 (2011).
14. Hirabayashi, M. et al. Rat transgenesis via embryonic stem cells electroporated with the Kusabira-orange gene. Mol. Reprod. Dev. 77, 474 (2010).
15. Tong, C., Li, P., Wu, N. L., Yan, Y. & Ying, Q. L. Production of p53 gene knockout rats by homologous recombination in embryonic stem cells. Nature 467, 211-213 (2010).
16. Donehower, L. A. et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356, 215-221 (1992).
17. Armstrong, J. F., Kaufman, M. H., Harrison, D. J. & Clarke, A. R. High-frequency developmental abnormalities in p53-deficient mice. Curr. Biol. 5, 931-936 (1995).
18. Sah, V. P. et al.A subset of p53-deficient embryos exhibit exencephaly. Nat. Genet. 10, 175-180 (1995).
19. Donehower, L. A. & Lozano, G. 20 years studying p53 functions in genetically engineered mice. Nat. Rev. Cancer 9, 831-841 (2009).
20. Huang, G. et al. Beyond knockout rats: new insights into finer genome manipulation in rats. Cell Cycle 10, 1059-1066 (2011).
21. van Boxtel, R. et al. Homozygous and heterozygous p53 knockout rats develop metastasizing sarcomas with high frequency. Am. J. Pathol. 179, 1616-1622 (2011).
22. Puzio-Kuter, A. M.&Levine, A. J. Stem cell biology meets p53. Nat. Biotechnol. 27, 914-915 (2009).
23. Lin, T. et al. p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression. Nat. Cell Biol. 7, 165-171 (2005). (Pubitemid 40268131)
24. Hong et al. Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature 460, 1132-1135 (2009).
25. Marion et al. A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity. Nature 460, 1149-1153 (2009).
26. Kawamata, M. & Ochiya, T. Establishment of embryonic stem cells from rat blastocysts. Methods Mol. Biol. 597, 169-177 (2010).
27. Kawamata, M. & Ochiya, T. Gene-manipulated embryonic stem cells for rat transgenesis. Cell Mol. Life Sci. 68, 1911-1915 (2011).
28. Hosako, H. et al. The roles of p53 and p21 in normal development and hyperthermia-induced malformations. Birth Defects Res. B Dev. Reprod. Toxicol. 86, 40-47 (2009).
29. Chen, X. et al. Sex difference in neural tube defects in p53-null mice is caused by differences in the complement of X not Y genes. Dev. Neurobiol. 68, 265-273 (2008). (Pubitemid 351199422)
30. Takemoto, T. et al. Tbx6-dependent Sox2 regulation determines neural or mesodermal fate in axial stem cells. Nature 470, 394-398 (2011).
31. Miyagi, S. et al. The Sox2 regulatory region 2 functions as a neural stem cellspecific enhancer in the telencephalon. J. Biol. Chem. 281, 13374-13381 (2006). (Pubitemid 43855248)
32. Hockemeyer, D. et al. Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases. Nat. Biotechnol. 27, 851-857 (2009).
33. Soldner, F. et al. Generation of Isogenic Pluripotent Stem Cells Differing Exclusively at Two Early Onset Parkinson Point Mutations. Cell 146, 318-331 (2011).
34. Meyer, M., de Angelis, M. H., Wurst, W. & Kühn, R. Gene targeting by homologous recombination in mouse zygotes mediated by zinc-finger nucleases. Proc. Natl. Acad. Sci. USA 107, 15022-15026 (2010).
35. Cui, X. et al. Targeted integration in rat and mouse embryos with zinc-finger nucleases. Nat. Biotechnol. 29, 64-67 (2011).
36. Abbott, A. Return to the rat. Nature 460, 788 (2009).
37. von Horsten, S. et al. Transgenic rat model of Huntington's disease. Hum. Mol. Genet. 12, 617-24 (2003).
38. Amos-Landgraf, J. M. et al. A target-selected Apc-mutant rat kindred enhances the modeling of familial human colon cancer. Proc. Natl. Acad. Sci. U.S.A. 104, 4036-41 (2007). (Pubitemid 47181574)